BnR Summit 2026

Belt & Road Summit - Deal-Making 2026

9 – 15 Sept 2026 | Hong Kong, China (Hong Kong)

Grid Biosciences

www.gridbiosciences.com/China (Hong Kong)
4 profile visits

About

Grid Biosciences is a biotech company developing (1) cancer vaccines, utilizing frontrunner immunotherapy and vaccine technologies. (2) Its bio manufacturing technology is developed by its Nobel Laureate advisor, enabling scaleable manufacturing infrastructure. Grid's pipeline includes vaccines/drugs for global cancers as well as cancers tied to Asian populations. (3) Further, Grid's AI platform discovers and designs unique cancer precision medicine based on a patient's own cancer DNA sequence.

Areas of activity

Technology

Bio-TechMedical Technology

Additional information

Other Place of Business

North America

Terms and Conditions & Disclaimer

I agree

Representatives

CEO

Grid Biosciences

Marketplace (1)

  • Project

    Nose Cancer Vaccine

    - Currently in a Phase 1 clinical trial - Next milestone aiming for FDA alignment and Phase 2 readiness

    • Yes
    • Yes
    • Bio-Tech
    • Technology
    • Private Project
    • Equity (private)
    • Financial Services
    • Investment / Financing Discussion
    Author

    CEO at Grid Biosciences

    China